IQ-AI Limited (IQAI.L) (LON:IQAI) Stock Price Up 28.1%


Share on StockTwits

IQ-AI Limited (IQAI.L) (LON:IQAI)’s share price rose 28.1% during trading on Thursday . The stock traded as high as GBX 12 ($0.16) and last traded at GBX 10.25 ($0.13). Approximately 4,143,412 shares traded hands during trading, an increase of 40% from the average daily volume of 2,960,623 shares. The stock had previously closed at GBX 8 ($0.10).

The company’s 50-day simple moving average is GBX 10.64 and its 200 day simple moving average is GBX 6.34. The stock has a market capitalization of £17.44 million and a price-to-earnings ratio of -17.08. The company has a quick ratio of 2.54, a current ratio of 4.11 and a debt-to-equity ratio of 3.49.

In other IQ-AI Limited (IQAI.L) news, insider Trevor Brown bought 3,566,667 shares of the business’s stock in a transaction on Tuesday, November 17th. The shares were bought at an average cost of GBX 2 ($0.03) per share, with a total value of £71,333.34 ($93,197.47). Over the last ninety days, insiders sold 18,979,197 shares of company stock worth $207,492,090.

IQ-AI Limited (IQAI.L) Company Profile (LON:IQAI)

IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey and the United States. Its products include IB Clinic, a toolkit of post-processing software plug-ins for integrating into existing medical image visualization applications; IB Rad Tech, a workflow engine that processes customized workflows; IB Neuro, which analyzes MR data sets and generates parametric perfusion maps quantifying changes in contrast over time; and IB Delta Suite that performs a various fundamental radiology operations, including image co-registration, subtraction, class map generation, and export.

Featured Story: Technical Analysis of Stocks and What It Means

Receive News & Ratings for IQ-AI Limited (IQAI.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQ-AI Limited (IQAI.L) and related companies with MarketBeat.com's FREE daily email newsletter.